2013 annual financial data
Vistagen Therapeutics 2013 Operating margin
Vistagen Therapeutics 2013 operating margin with verified reported values.
Direct answer
Operating margin was -3,389.77%.
Operating income was -6,793,100 USD and net income was -12,886,700 USD.
Operating cash flow was -3,463,200 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 200,400 USD
- Operating income
- -6,793,100 USD
- Net income
- -12,886,700 USD
- Operating cash flow
- -3,463,200 USD